Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Number of toxicities associated with GFIP/BDC

From: Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer

Toxicity None Grade 1 Grade 2 Grade 3 Grade 4
Hematologic 3 1 11 4 1
Constitutional 7 2 8 2 0
Gastrointestinal 14 0 3 2 0
Nutrition 18 0 1 1 0
Neurologic 18 1 1 2 0
Pain 19 0 1 0 0
Vascular 19 0 0 1 0
General 19 0 1 0 0